These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16725385)

  • 1. Simultaneous determination of gemcitabine di- and triphosphate in human blood mononuclear and cancer cells by RP-HPLC and UV detection.
    Losa R; Sierra MI; Gión MO; Esteban E; Buesa JM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Aug; 840(1):44-9. PubMed ID: 16725385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new, simple method for quantifying gemcitabine triphosphate in cancer cells using isocratic high-performance liquid chromatography.
    Nishi R; Yamauchi T; Ueda T
    Cancer Sci; 2006 Nov; 97(11):1274-8. PubMed ID: 17034368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid determination of gemcitabine in plasma and serum using reversed-phase HPLC.
    Lanz C; Früh M; Thormann W; Cerny T; Lauterburg BH
    J Sep Sci; 2007 Aug; 30(12):1811-20. PubMed ID: 17638352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validated assays for the determination of gemcitabine in human plasma and urine using high-performance liquid chromatography with ultraviolet detection.
    Freeman KB; Anliker S; Hamilton M; Osborne D; Dhahir PH; Nelson R; Allerheiligen SR
    J Chromatogr B Biomed Appl; 1995 Mar; 665(1):171-81. PubMed ID: 7795789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of gemcitabine and its metabolite in human plasma by high-performance liquid chromatography.
    Yilmaz B; Kadioğlu YY; Aksoy Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):103-9. PubMed ID: 12798170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of zero- and second-order derivative spectrophotometric and HPLC methods for the determination of gemcitabine in human plasma.
    Yilmaz B; Kadioğlu Y
    Farmaco; 2004 May; 59(5):425-9. PubMed ID: 15120323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatography/tandem mass spectrometry method for simultaneous quantification of eight endogenous nucleotides and the intracellular gemcitabine metabolite dFdCTP in human peripheral blood mononuclear cells.
    Kamčeva T; Bjånes T; Svardal A; Riedel B; Schjøtt J; Eide T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():212-20. PubMed ID: 26281773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of the anti-cancer agent gemcitabine in human plasma by high-performance liquid chromatography.
    Keith B; Xu Y; Grem JL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Feb; 785(1):65-72. PubMed ID: 12535839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2',2'-difluorodeoxyuridine and their nucleotides.
    Derissen EJB; Huitema ADR; Rosing H; Schellens JHM; Beijnen JH
    Br J Clin Pharmacol; 2018 Jun; 84(6):1279-1289. PubMed ID: 29451684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of gemcitabine triphosphate in human peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry.
    Veltkamp SA; Hillebrand MJ; Rosing H; Jansen RS; Wickremsinhe ER; Perkins EJ; Schellens JH; Beijnen JH
    J Mass Spectrom; 2006 Dec; 41(12):1633-42. PubMed ID: 17117372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of gemcitabine and its metabolite in extracellular fluid of rat brain tumor by ultra performance liquid chromatography-tandem mass spectrometry using microdialysis sampling after intralesional chemotherapy.
    Sun Y; Tang D; Chen H; Zhang F; Fan B; Zhang B; Fang S; Lu Q; Wei Y; Yin J; Yin X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 919-920():10-9. PubMed ID: 23396113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isocratic ion-exchange chromatographic assay for the nucleotide gemcitabine triphosphate in human white blood cells.
    Sparidans RW; Crul M; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(2):423-30. PubMed ID: 12401370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a stability indicating isocratic HPLC method for gemcitabine with application to drug release from poly lactic-co-glycolic acid nanoparticles and enzymatic degradation studies.
    Chen G; Svirskis D; Wen J
    J Pharm Pharmacol; 2015 Nov; 67(11):1528-36. PubMed ID: 26369422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An expedient assay for determination of gemcitabine and its metabolite in human plasma using isocratic ion-pair reversed-phase high-performance liquid chromatography.
    Wang LZ; Goh BC; Lee HS; Noordhuis P; Peters GJ
    Ther Drug Monit; 2003 Oct; 25(5):552-7. PubMed ID: 14508377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry.
    Marangon E; Sala F; Caffo O; Galligioni E; D'Incalci M; Zucchetti M
    J Mass Spectrom; 2008 Feb; 43(2):216-23. PubMed ID: 17941128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of capecitabine and its metabolite 5-fluorouracil by column switching and liquid chromatographic/tandem mass spectrometry.
    Siethoff C; Orth M; Ortling A; Brendel E; Wagner-Redeker W
    J Mass Spectrom; 2004 Aug; 39(8):884-9. PubMed ID: 15329840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous quantification of Gemcitabine and Irinotecan hydrochloride in rat plasma by using high performance liquid chromatography-diode array detector.
    Malatesta L; Cosco D; Paolino D; Cilurzo F; Costa N; Di Tullio A; Fresta M; Celia C; Di Marzio L; Locatelli M
    J Pharm Biomed Anal; 2018 Sep; 159():192-199. PubMed ID: 29990886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic method for the determination of gemcitabine and 2',2'-difluorodeoxyuridine in plasma and tissue culture media.
    Kirstein MN; Hassan I; Guire DE; Weller DR; Dagit JW; Fisher JE; Remmel RP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 835(1-2):136-42. PubMed ID: 16584929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validated assay for the simultaneous determination of the anti-cancer agent gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma by high-performance liquid chromatography with tandem mass spectrometry.
    Vainchtein LD; Rosing H; Thijssen B; Schellens JH; Beijnen JH
    Rapid Commun Mass Spectrom; 2007; 21(14):2312-22. PubMed ID: 17577879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of Gemcitabine in Plasma of Bladder Cancer Patients by Hydrophilic Interaction Chromatography with Ultraviolet Detection.
    Wang M; Hiraki R; Nakamura N; Hayama T; Yasuda T; Miyata Y; Sakai H; Nakashima MN; Nakashima M; Ohyama K
    J Chromatogr Sci; 2020 Jul; 58(7):587-590. PubMed ID: 32448890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.